Abstract 12681: Implication of Aurora Kinase B in Pulmonary Arterial Hypertension
Mélanie Sauvaget(Canadian Heart Research Centre), Sébastien Bonnet(Institut universitaire de cardiologie et de pneumologie de Québec), Sarah‐Eve Lemay(SNC-Lavalin (Canada)), Mark Orcholski, Kana Schimauchi(Institut universitaire de cardiologie et de pneumologie de Québec), Olivier Boucherat, Roxane Paulin, Ghada Mkannez(Université Laval), Sandra Breuils Bonnet(Université Laval), François Potus(Queen's University)
Cited by 0
Related Papers
A Mitochondria-K+ Channel Axis Is Suppressed in Cancer and Its Normalization Promotes Apoptosis and Inhibits Cancer Growth
|Cancer Cell|2007|1.5k
Novel Mutations and Decreased Expression of the Epigenetic Regulator <i>TET2</i> in Pulmonary Arterial Hypertension
|Circulation|2020|120
Defining the clinical validity of genes reported to cause pulmonary arterial hypertension
|Genetics in Medicine|2023|73
DNA methylation of a PLPP3 MIR transposon-based enhancer promotes an osteogenic programme in calcific aortic valve disease
|Cardiovascular Research|2018|40
Oxidized DNA Precursors Cleanup by NUDT1 Contributes to Vascular Remodeling in Pulmonary Arterial Hypertension
|American Journal of Respiratory and Critical Care Medicine|2020|34